Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

FGF19 overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

FGF19 overexpression	Hepatocellular Cancer	FGF19 overexpression	Hepatocellular Cancer	ABSK011 Sensitive: C2 – Inclusion Criteria ABSK011 Sensitive : C2	ABSK011 Sensitive: C2 – Inclusion Criteria ABSK011 Sensitive : C2
FGF19 overexpression	Hepatocellular Cancer	FGF19 overexpression	Hepatocellular Cancer	BLU-554 Sensitive: C3 – Early Trials BLU-554 Sensitive : C3	BLU-554 Sensitive: C3 – Early Trials BLU-554 Sensitive : C3
FGF19 overexpression	Hepatocellular Cancer	FGF19 overexpression	Hepatocellular Cancer	FGF401 Sensitive: D – Preclinical FGF401 Sensitive : D	FGF401 Sensitive: D – Preclinical FGF401 Sensitive : D
FGF19 overexpression	Hepatocellular Cancer	FGF19 overexpression	Hepatocellular Cancer	H3B-6527 Sensitive: D – Preclinical H3B-6527 Sensitive : D	H3B-6527 Sensitive: D – Preclinical H3B-6527 Sensitive : D
FGF19 overexpression	Hepatocellular Cancer	FGF19 overexpression	Hepatocellular Cancer	palbociclib + H3B-6527 Sensitive: D – Preclinical palbociclib + H3B-6527 Sensitive : D	palbociclib + H3B-6527 Sensitive: D – Preclinical palbociclib + H3B-6527 Sensitive : D
FGF19 overexpression	Hepatocellular Cancer	FGF19 overexpression	Hepatocellular Cancer	sorafenib Resistant: D – Preclinical sorafenib Resistant : D	sorafenib Resistant: D – Preclinical sorafenib Resistant : D